KINIKSA PHARMACEUTICALS INTE

KNSANASDAQ

🏆 #1208 by market capEarnings Oct 26US Equity

$1,003.79▼ $49.59 (−4.94%)

Simulated price

Get earnings, price moves & breaking news on Telegram

24h▼ 4.9%

7d▲ 1219.4%

14d▲ 1195.5%

30d▲ 1177.1%

ytd▲ 2337.6%

1y▲ 2482.4%

🏦Market Cap

$5.77B

Small Cap

📈Revenue Growth (YoY)

+60.1%

High Growth

📊Gross Margin

54.5%

Healthy

💵FCF Margin

21.8%

Strong

⚖️P/S Ratio

6.9x

Fair

Otter Score

56

Weak

Earnings

Q2 · 2026Reported 2026-06-30

Earnings Per Share

Actual

0.30

Expected

0.30

miss

−1.50%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q2 2026

0.30

miss

Q1 2026

0.27

beat

Q4 2025

0.17

miss

Q3 2025

0.23

miss